Development of an EGFR-targeting Alginate-based Injectable Hydrogel Drug Delivery System for the Improved Treatment of Solid Malignancies.
dc.contributor.advisor | Yevgeny Brudno, Chair | |
dc.contributor.advisor | Duncan Lascelles, Member | |
dc.contributor.advisor | Paul Hess, Member | |
dc.contributor.advisor | David Zaharoff, Member | |
dc.contributor.author | Ferrell, Tiffany Rae | |
dc.date.accepted | 2022-01-06 | |
dc.date.accessioned | 2022-01-11T13:30:20Z | |
dc.date.available | 2022-01-11T13:30:20Z | |
dc.date.defense | 2021-08-27 | |
dc.date.issued | 2021-08-27 | |
dc.date.released | 2022-01-11 | |
dc.date.reviewed | 2021-09-13 | |
dc.date.submitted | 2021-09-09 | |
dc.degree.discipline | Comparative Biomedical Sci | |
dc.degree.level | thesis | |
dc.degree.name | Master of Science | |
dc.identifier.other | deg26945 | |
dc.identifier.uri | https://www.lib.ncsu.edu/resolver/1840.20/39359 | |
dc.title | Development of an EGFR-targeting Alginate-based Injectable Hydrogel Drug Delivery System for the Improved Treatment of Solid Malignancies. |
Files
Original bundle
1 - 1 of 1